Works matching AU Mori, Masahide


Results: 63
    1
    2

    Polymorphisms of CYP2D6 Gene and Gefitinib-Induced Hepatotoxicity.

    Published in:
    Clinical Lung Cancer, 2013, v. 14, n. 5, p. 502, doi. 10.1016/j.cllc.2013.03.003
    By:
    • Takayuki Takimoto;
    • Takashi Kijima;
    • Yasushi Otani;
    • Shinpei Nonen;
    • Yoshinobu Namba;
    • Masahide Mori;
    • Soichiro Yokota;
    • Seigo Minami;
    • Kiyoshi Komuta;
    • Junji Uchida;
    • Fumio Imamura;
    • Mitsugi Furukawa;
    • Naotoshi Tsuruta;
    • Yasushi Fujio;
    • Junichi Azuma;
    • Isao Tachibana;
    • Atsushi Kumanogoh
    Publication type:
    Article
    3
    4
    5

    Chronic Pulmonary Disease Caused by Tsukamurella toyonakaense.

    Published in:
    2022
    By:
    • Tomoki Kuge;
    • Kiyoharu Fukushima;
    • Yuki Matsumoto;
    • Haruko Saito;
    • Yuko Abe;
    • Eri Akiba;
    • Kako Haduki;
    • Tadayoshi Nitta;
    • Akira Kawano;
    • Michio Tanaka;
    • Yumi Hattori;
    • Takahiro Kawasaki;
    • Takanori Matsuki;
    • Takayuki Shiroyama;
    • Daisuke Motooka;
    • Kazuyuki Tsujino;
    • Keisuke Miki;
    • Masahide Mori;
    • Seigo Kitada;
    • Shota Nakamura
    Publication type:
    journal article
    6
    7
    8

    Risk Stratification According to Baseline and Early Change in Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Treated with Chemoimmunotherapy: A Multicenter Real-World Study.

    Published in:
    Targeted Oncology, 2024, v. 19, n. 5, p. 757, doi. 10.1007/s11523-024-01084-7
    By:
    • Matsumoto, Kinnosuke;
    • Yamamoto, Yuji;
    • Shiroyama, Takayuki;
    • Kuge, Tomoki;
    • Mori, Masahide;
    • Tamiya, Motohiro;
    • Kinehara, Yuhei;
    • Tamiya, Akihiro;
    • Suzuki, Hidekazu;
    • Tobita, Satoshi;
    • Ueno, Kiyonobu;
    • Niki, Toshie;
    • Nagatomo, Izumi;
    • Takeda, Yoshito;
    • Kumanogoh, Atsushi
    Publication type:
    Article
    9
    10

    NHERF2 as a Novel Biomarker for Distinguishing MAC Pulmonary Disease from Tuberculosis Based on Proteome Analysis of Serum Extracellular Vesicles.

    Published in:
    International Journal of Molecular Sciences, 2025, v. 26, n. 3, p. 1155, doi. 10.3390/ijms26031155
    By:
    • Naito, Maiko;
    • Takeda, Yoshito;
    • Edahiro, Ryuya;
    • Shirai, Yuya;
    • Enomoto, Takatoshi;
    • Nakayama, Mana;
    • Nojima, Satoshi;
    • Nogami-Ito, Mari;
    • Mori, Masahide;
    • Yano, Yukihiro;
    • Matsuki, Takanori;
    • Yoshimura, Hanako;
    • Hara, Reina;
    • Yamamoto, Makoto;
    • Masuhiro, Kentaro;
    • Naito, Yujiro;
    • Koyama, Shohei;
    • Iwahori, Kota;
    • Nagatomo, Izumi;
    • Shiroyama, Takayuki
    Publication type:
    Article
    11

    A case of acute and severe thrombocytopenia due to readministration of rifampicin.

    Published in:
    Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 2011, v. 17, n. 2, p. 288, doi. 10.1007/s10156-010-0117-x
    By:
    • Mori, Masahide;
    • Izawa, Kazutaka;
    • Fujikawa, Takeya;
    • Uenami, Takeshi;
    • Sugano, Teppei;
    • Kagami, Sin-ichi;
    • Namba, Yoshinobu;
    • Yano, Yukihiro;
    • Yoneda, Tsutomu;
    • Kitada, Seigo;
    • Kimura, Hiromi;
    • Yamaguchi, Toshihiko;
    • Yokota, Soichiro;
    • Maekura, Ryoji
    Publication type:
    Article
    12

    Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 1, p. 1, doi. 10.1007/s00262-023-03583-4
    By:
    • Matsumoto, Kinnosuke;
    • Shiroyama, Takayuki;
    • Tamiya, Motohiro;
    • Minami, Toshiyuki;
    • Kinehara, Yuhei;
    • Tamiya, Akihiro;
    • Suga, Yasuhiko;
    • Kuge, Tomoki;
    • Mori, Masahide;
    • Suzuki, Hidekazu;
    • Tobita, Satoshi;
    • Ueno, Kiyonobu;
    • Namba, Yoshinobu;
    • Tetsumoto, Satoshi;
    • Niki, Toshie;
    • Morimura, Osamu;
    • Osa, Akio;
    • Nishino, Kazumi;
    • Nagatomo, Izumi;
    • Takeda, Yoshito
    Publication type:
    Article
    13

    Minimal influence of tocilizumab on IFN-γ synthesis by tuberculosis antigens.

    Published in:
    Modern Rheumatology, 2010, v. 20, n. 2, p. 130, doi. 10.3109/s10165-009-0243-4
    By:
    • Ogata, Atsushi;
    • Mori, Masahide;
    • Hashimoto, Shoji;
    • Yano, Yukihiro;
    • Fujikawa, Takeya;
    • Kawai, Mari;
    • Kuwahara, Yusuke;
    • Hirano, Toru;
    • Arimitsu, Junsuke;
    • Hagihara, Keisuke;
    • Shima, Yoshihito;
    • Narazaki, Masashi;
    • Yokota, Souichirou;
    • Kishimoto, Tadamitsu;
    • Kawase, Ichiro;
    • Tanaka, Toshio
    Publication type:
    Article
    14
    15
    16
    17

    Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status.

    Published in:
    BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-03212-5
    By:
    • Taniguchi, Yoshihiko;
    • Tamiya, Akihiro;
    • Osuga, Mitsuo;
    • Harada, Daijiro;
    • Isa, Shun-ichi;
    • Nakamura, Keiichi;
    • Mizumori, Yasuyuki;
    • Shinohara, Tsutomu;
    • Yanai, Hidetoshi;
    • Nakatomi, Katsumi;
    • Oki, Masahide;
    • Mori, Masahide;
    • Kuwako, Tomohito;
    • Yamazaki, Koji;
    • Tamura, Atsuhisa;
    • Ando, Masahiko;
    • Koh, Yasuhiro
    Publication type:
    Article
    18
    19
    20

    A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41051-2
    By:
    • Iwahori, Kota;
    • Nii, Takuro;
    • Yamaguchi, Norihiko;
    • Kawasaki, Takahiro;
    • Okamura, Satomi;
    • Hashimoto, Kazuki;
    • Matsuki, Takanori;
    • Tsujino, Kazuyuki;
    • Miki, Keisuke;
    • Osa, Akio;
    • Goya, Sho;
    • Abe, Kinya;
    • Mori, Masahide;
    • Takeda, Yoshito;
    • Yamada, Tomomi;
    • Kida, Hiroshi;
    • Kumanogoh, Atsushi
    Publication type:
    Article
    21

    Significance of micro-EGFR T790M mutations on EGFR-tyrosine kinase inhibitor efficacy in non-small cell lung cancer.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45337-3
    By:
    • Masuda, Takeshi;
    • Miura, Satoru;
    • Sato, Yuki;
    • Tachihara, Motoko;
    • Bessho, Akihiro;
    • Nakamura, Atsushi;
    • Miyawaki, Taichi;
    • Yoshimine, Kohei;
    • Mori, Masahide;
    • Shiraishi, Hideaki;
    • Hamai, Kosuke;
    • Haratani, Koji;
    • Maeda, Sumiko;
    • Tabata, Eriko;
    • Kitagawa, Chiyoe;
    • Tanizaki, Junko;
    • Imai, Takumi;
    • Nogami, Shohei;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    22

    A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41051-2
    By:
    • Iwahori, Kota;
    • Nii, Takuro;
    • Yamaguchi, Norihiko;
    • Kawasaki, Takahiro;
    • Okamura, Satomi;
    • Hashimoto, Kazuki;
    • Matsuki, Takanori;
    • Tsujino, Kazuyuki;
    • Miki, Keisuke;
    • Osa, Akio;
    • Goya, Sho;
    • Abe, Kinya;
    • Mori, Masahide;
    • Takeda, Yoshito;
    • Yamada, Tomomi;
    • Kida, Hiroshi;
    • Kumanogoh, Atsushi
    Publication type:
    Article
    23
    24

    Carboplatin plus weekly nanoparticle albumin-bound paclitaxel in elderly patients with previously untreated advanced squamous non-small-cell lung cancer selected based on Mini Nutritional Assessment short-form scores: a multicenter phase 2 study.

    Published in:
    2017
    By:
    • Shiroyama, Takayuki;
    • Tamiya, Motohiro;
    • Minami, Seigo;
    • Takata, So;
    • Masuhiro, Kentaro;
    • Futami-Nishijima, Yu;
    • Uenami, Takeshi;
    • Mori, Masahide;
    • Koba, Taro;
    • Matsuki, Takanori;
    • Takimoto, Takayuki;
    • Suzuki, Hidekazu;
    • Okamoto, Norio;
    • Komuta, Kiyoshi;
    • Hirashima, Tomonori;
    • Kumanogoh, Atsushi;
    • Kijima, Takashi
    Publication type:
    journal article
    25
    26

    WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor.

    Published in:
    International Journal of Cancer, 2009, v. 125, n. 2, p. 381, doi. 10.1002/ijc.24367
    By:
    • Oji, Yusuke;
    • Kitamura, Yayoi;
    • Kamino, Eriko;
    • Kitano, Aiko;
    • Sawabata, Noriyoshi;
    • Inoue, Masayoshi;
    • Mori, Masahide;
    • Nakatsuka, Shin-ichi;
    • Sakaguchi, Nao;
    • Miyazaki, Kaori;
    • Nakamura, Michiyo;
    • Fukuda, Ikuyo;
    • Nakamura, Junya;
    • Tatsumi, Naoya;
    • Takakuwa, Tetsuya;
    • Nishida, Sumiyuki;
    • Shirakata, Toshiaki;
    • Hosen, Naoki;
    • Tsuboi, Akihiro;
    • Nezu, Riichiro
    Publication type:
    Article
    27
    28

    Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non–Small Cell Lung Cancer.

    Published in:
    JAMA Network Open, 2023, v. 6, n. 12, p. e2347700, doi. 10.1001/jamanetworkopen.2023.47700
    By:
    • Sakamoto, Tomohiro;
    • Matsubara, Taichi;
    • Takahama, Takayuki;
    • Yokoyama, Toshihide;
    • Nakamura, Atsushi;
    • Tokito, Takaaki;
    • Okamoto, Tatsuro;
    • Akamatsu, Hiroaki;
    • Oki, Masahide;
    • Sato, Yuki;
    • Tobino, Kazunori;
    • Ikeda, Satoshi;
    • Mori, Masahide;
    • Mimura, Chihiro;
    • Maeno, Ken;
    • Miura, Satoru;
    • Harada, Toshiyuki;
    • Nishimura, Kunihiro;
    • Hiraoka, Manabu;
    • Kenmotsu, Hirotsugu
    Publication type:
    Article
    29
    30
    31

    Circulating Tumour DNA in Patients With EGFR‐Mutated Non‐Small‐Cell Lung Cancer and Early Disease Progression After First‐Line Osimertinib Treatment: The ELUCIDATOR Multicentre Prospective Observational Study.

    Published in:
    Cancer Medicine, 2025, v. 14, n. 7, p. 1, doi. 10.1002/cam4.70861
    By:
    • Tamiya, Akihiro;
    • Mizumori, Yasuyuki;
    • Osuga, Mitsuo;
    • Isa, Shun‐ichi;
    • Taniguchi, Yoshihiko;
    • Nakamura, Keiichi;
    • Harada, Daijiro;
    • Shinohara, Tsutomu;
    • Yanai, Hidetoshi;
    • Nakatomi, Katsumi;
    • Oki, Masahide;
    • Mori, Masahide;
    • Kuwako, Tomohito;
    • Yamazaki, Koji;
    • Tamura, Atsuhisa;
    • Ando, Masahiko;
    • Koh, Yasuhiro
    Publication type:
    Article
    32

    Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC.

    Published in:
    Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-58186-7
    By:
    • Tanaka, Kentaro;
    • Sugisaka, Jun;
    • Shiraishi, Yoshimasa;
    • Watanabe, Yasutaka;
    • Daga, Haruko;
    • Azuma, Koichi;
    • Nishino, Kazumi;
    • Mori, Masahide;
    • Ota, Takayo;
    • Saito, Haruhiro;
    • Hata, Akito;
    • Sakaguchi, Tadashi;
    • Kozuki, Toshiyuki;
    • Akamatsu, Hiroaki;
    • Matsumoto, Hirotaka;
    • Tachihara, Motoko;
    • Wakuda, Kazushige;
    • Sato, Yuki;
    • Ozaki, Tomohiro;
    • Tsuchiya-Kawano, Yuko
    Publication type:
    Article
    33

    Hepatoma-Derived Growth Factor Is Involved in Lung Remodeling by Stimulating Epithelial Growth.

    Published in:
    American Journal of Respiratory Cell & Molecular Biology, 2004, v. 30, n. 4, p. 459, doi. 10.1165/rcmb.2003-0013OC
    By:
    • Masahide Mori;
    • Hiroshi Morishita;
    • Hideji Nakamura;
    • Hiroto Matsuoka;
    • Kenya Yoshida;
    • Yoshihiko Kishima;
    • Zhiwei Zhou;
    • Hiroshi Kida;
    • Toshiki Funakoshi;
    • Sho Goya;
    • Mitsuhiro Yoshida;
    • Toru Kumagai;
    • Isao Tachibana;
    • Yoichi Yamamoto;
    • Ichiro Kawase;
    • Seiji Hayashi
    Publication type:
    Article
    34
    35

    The Extracellular Domain of p185<sup>c-neu</sup> Induces Density-Dependent Inhibition of Cell Growth in Malignant Mesothelioma Cells and Reduces Growth of Mesothelioma In Vivo.

    Published in:
    DNA & Cell Biology, 2006, v. 25, n. 9, p. 530, doi. 10.1089/dna.2006.25.530
    By:
    • Yoneda, Tsutomu;
    • Kumagai, Toru;
    • Nagatomo, Izumi;
    • Furukawa, Mitsugi;
    • Yamane, Hiroyuki;
    • Hoshino, Shigenori;
    • Mori, Masahide;
    • Takeda, Yoshito;
    • Horai, Takeshi;
    • Nishida, Sumiyuki;
    • Watanabe, Dai;
    • Kijima, Takashi;
    • Yoshida, Mitsuhiro;
    • Osaki, Tadashi;
    • Tachibana, Isao;
    • Greene, Mark I.;
    • Kawase, Ichiro
    Publication type:
    Article
    36

    A Phase II Study of Pemetrexed in Chemotherapy-naïve Elderly Patients Aged ≥75 years with Advanced Non-squamous Non-small-cell Lung Cancer (HANSHIN Oncology Group 003).

    Published in:
    Japanese Journal of Clinical Oncology, 2013, v. 43, n. 12, p. 1184, doi. 10.1093/jjco/hyt159
    By:
    • Hattori, Yoshihiro;
    • Iwasaku, Masahiro;
    • Satouchi, Miyako;
    • Nishiyama, Akihiro;
    • Korogi, Yohei;
    • Otsuka, Kojiro;
    • Fujita, Shiro;
    • Katakami, Nobuyuki;
    • Mori, Masahide;
    • Nishino, Kazumi;
    • Morita, Satoshi;
    • Negoro, Shunichi
    Publication type:
    Article
    37

    Clinical benefit of platinum doublet combination therapy in older adults with advanced non‐small cell lung cancer: A prospective multicenter study by the National Hospital Organization in Japan.

    Published in:
    Thoracic Cancer, 2023, v. 14, n. 17, p. 1597, doi. 10.1111/1759-7714.14904
    By:
    • Shimokawa, Mototsugu;
    • Kanazu, Masaki;
    • Saito, Ryusei;
    • Mori, Masahide;
    • Tamura, Atsuhisa;
    • Okano, Yoshio;
    • Fujita, Yuka;
    • Endo, Takeo;
    • Motegi, Mitsuru;
    • Takata, Shohei;
    • Kita, Toshiyuki;
    • Sukoh, Noriaki;
    • Mizuki, Fumitaka;
    • Takenoyama, Mitsuhiro;
    • Atagi, Shinji
    Publication type:
    Article
    38
    39

    A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non‐small cell lung cancer harboring EGFR mutations (JMTO LC12‐01).

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 12, p. 1827, doi. 10.1111/1759-7714.14465
    By:
    • Asami, Kazuhiro;
    • Ando, Masahiko;
    • Nishimura, Takashi;
    • Yokoi, Takashi;
    • Tamura, Atsuhisa;
    • Minato, Koichi;
    • Mori, Masahide;
    • Ogushi, Fumitaka;
    • Yamamoto, Akiyoshi;
    • Yoshioka, Hiroshige;
    • Kawahara, Masaaki;
    • Atagi, Shinji
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Clinical factors associated with shorter durable response, and patterns of acquired resistance to first-line pembrolizumab monotherapy in PD-L1-positive non-small-cell lung cancer patients: a retrospective multicenter study.

    Published in:
    2021
    By:
    • Hosoya, Kazutaka;
    • Fujimoto, Daichi;
    • Morimoto, Takeshi;
    • Kumagai, Toru;
    • Tamiya, Akihiro;
    • Taniguchi, Yoshihiko;
    • Yokoyama, Toshihide;
    • Ishida, Tadashi;
    • Matsumoto, Hirotaka;
    • Hirano, Katsuya;
    • Kominami, Ryota;
    • Tomii, Keisuke;
    • Suzuki, Hidekazu;
    • Hirashima, Tomonori;
    • Tanaka, Satoshi;
    • Uchida, Junji;
    • Morita, Mitsunori;
    • Kanazu, Masaki;
    • Mori, Masahide;
    • Nagata, Kenji
    Publication type:
    journal article
    50